A. Petitta

Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke

M Frankel, J. Broderick, J. Marler, 1998, Neurology.

Assessing the Value of Pharmacists' Health‐Systemwide Services: Clinical Pathways and Treatment Guidelines

A. Petitta, 2000, Pharmacotherapy.

Economic Evaluation of Three Methods of Treating Urogenital Chlamydial Infections in the Emergency Department

E. Bailey, A. Petitta, S. Hart, 1999, Pharmacotherapy.

Retrospective Pharmacoeconomic Evaluation of Dosing Vecuronium by Peripheral Nerve Stimulation versus Standard Clinical Assessment in Critically Ill Patients

M. Rudis, B. Zarowitz, A. Petitta, 1997, Pharmacotherapy.

The Economic Impact of Irritable Bowel Syndrome in a Managed Care Setting

B. Zarowitz, R. Fogel, E. Peterson, 2002, Journal of clinical gastroenterology.

COMPARATM RESEARCH : The Cost-Effectiveness Impact of a Preferred Agent HMG-CoA Reductase Inhibitor Policy in a Managed Care

Alan M. Johnson, R. E. Ward, A. Petitta, 2005 .